← Leaderboards
Steve Durako
Westat, Inc.
$1,229,437
Attributed
$1,229,437
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $260.6K · FY2013–17$500K$375K$250K$125K$0
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$1,229,437 · 1
By mechanism
N02$759,350 · 1
N01$470,087 · 1
Top collaborators
No co-investigators on record.
Most similar at Westat, Inc.
Same institution · by research overlap
- Barbara Driver$270,069,085
- Marsha Dunn$12,357,555
- Russell Walker$15,990,748
- Sunitha Mathew$31,488,437
- Detra Robinson$15,000,418
Others in their field
Top investigators on “United States Public Health Service”
- David R. Weir · University Of Michigan At Ann Arbor$153,553,286
- George R Seage · Abt Associates, Inc.$130,650,446
- David Heimbrook · Leidos Biomedical Research, Inc.$103,670,668
- Elizabeth A Thom · George Washington University$102,775,852
- Jeffrey H Samet · Boston University Medical Campus$84,919,550
- Sharon L. Walsh · University Of Kentucky$82,415,922
Research focus
United States Public Health ServiceBrain DiseasesCenters For Disease Control And Prevention (U.S.)Cessation Of LifeChildCohortContractorCreutzfeldt-Jakob SyndromeUnited StatesAttentionFollow-UpGrowthNational Institute Of Child Health And Human DevelopmentNational Institute Of Diabetes And Digestive And Kidney DiseasesNational Institute Of Neurological Disorders And StrokePhysiciansPituitary HormonesProgramsServicesSomatropinFailure (Biologic Function)Failure
Grant awards (5)
CREUTZFELDT-JAKOB DISEASE SURVEILLANCE IN RECIPIENTS OF HUMAN GROWTH HORMONE$260,634
N02 · FY2017 · LM · contact PI
CREUTZFELDT-JAKOB DISEASE SURVEILLANCE IN RECIPIENTS OF HUMAN GROWTH HORMONE$253,043
N02 · FY2016 · LM · contact PI
IGF::OT::IGF CREUTZFELDT-JAKOB DISEASE SURVEILLANCE IN RECIPIENTS OF HUMAN GROWT$245,673
N02 · FY2015 · LM · contact PI
IGF::OT::IGF CREUTZFELDT-JAKOB DISEASE SURVEILLANCE IN RECIPIENTS OF HUMAN GROWT$238,517
N01 · FY2014 · LM · contact PI
IGF::OT::IGF CREUTZFELDT-JAKOB DISEASE SURVEILLANCE IN RECIPIENTS OF HUMAN GROWT$231,570
N01 · FY2013 · LM · contact PI